Viewing Study NCT05101356


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2025-12-25 @ 9:27 PM
Study NCT ID: NCT05101356
Status: RECRUITING
Last Update Posted: 2024-05-21
First Post: 2021-10-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma
Sponsor:
Organization: